# Vinorelbine in Advanced BRAF-like Colon Cancer

> **NCT03482362** · PHASE2 · COMPLETED · sponsor: **The Netherlands Cancer Institute** · enrollment: 1 (actual)

## Conditions studied

- Colon Cancer

## Interventions

- **DRUG:** Vinorelbine Tartrate

## Key facts

- **NCT ID:** NCT03482362
- **Lead sponsor:** The Netherlands Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-03-01
- **Primary completion:** 2020-03-17
- **Final completion:** 2020-03-17
- **Target enrollment:** 1 (ACTUAL)
- **Last updated:** 2025-08-03

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03482362

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03482362, "Vinorelbine in Advanced BRAF-like Colon Cancer". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT03482362. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*